anacetrapib anacetrapib anacetrapib is a cetp inhibitor which was being developed to treat elevated cholesterol levels in an effort to prevent cardiovascular disease. in 2017 its development was abandoned by merck. anacetrapib names preferred iupac name (4s,5r)-5--3--4-methyl-1,3-oxazolidin-2-one other names mk-0859 identifiers cas number 875446-37-0 y 3d model (jsmol) interactive image chembl chembl1800807 n chemspider 9731205 y kegg d08855 y pubchem cid 11556427 unii p7t269pr6s y comptox dashboard (epa) dtxsid90236452 inchi inchi=1s/c30h25f10no3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26h,13h2,1-4h3/t15-,26-/m0/s1 ykey: mzzlgjhlqguvpn-hawmadmcsa-n yinchi=1/c30h25f10no3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26h,13h2,1-4h3/t15-,26-/m0/s1key: mzzlgjhlqguvpn-hawmadmcbn smiles o=c2o(c1cc(cc(c1)c(f)(f)f)c(f)(f)f)(n2cc4c(c3cc(c(f)cc3oc)c(c)c)ccc(c4)c(f)(f)f)c properties chemical formula c30h25f10no3 molar mass 637.51 g·mol−1 except where otherwise noted, data are given for materials in their standard state (at 25 °c , 100 kpa). n verify (what is yn ?) infobox references evidence in 2017 reveal trial anacetrapib was shown to decrease the risk of repeat heart attacks in high-risk patients with previous acute coronary events.